OGCTs | OSCs | P value | ORa | |
---|---|---|---|---|
Imaging findings | ||||
T1 signals | 20 | 34 | 0.017 | |
hypointensity | 4 | 8 | ||
isointensity | 5 | 26 | ||
hyperintensity | 5 | |||
mixed | 6 | |||
T2 signals | 0.002 | |||
hypointensity | 5 | |||
isointensity | 1 | 12 | ||
hyperintensity | 12 | 10 | ||
mixed | 7 | 7 | ||
DWI signals | 0.003 | |||
hypointensity | 1 | 7 | ||
isointensity | 3 | 11 | ||
hyperintensity | 16 | 16 | ||
mixed | ||||
Margin | 0.326 | 0.172 | ||
Regular/Iregular | 17/3 | 33/1 | ||
Capsule | 0.015 | 0.800 | ||
Present/Absent | 16/4 | 34/0 | ||
Hemorrhage | 0.001 | 3.429 | ||
Present/Absent | 6/14 | 0/34 | ||
Component | 0.000 | 2.50 | ||
Solid(80–100% solid component) | 8 | 28 | ||
Cyst (80–100% cystic component) | 4 | 1 | ||
Solid with cystic changes (others) | 8 | 5 | ||
Enhancement (homogeneous/inhomogeneous) | 0.034 | |||
minor | 16(16/0) | |||
mild | 14(12/2) | 10(7/3) | ||
moderate | 6(5/1) | 4(4/0) | ||
avid | 4(1/3) | |||
Maximum diameter (mm) | 9.33 ± 5.43 | 8.5 ± 8.9 | 0.753 | |
< 5 | 6 | 17 | ||
5–10 | 9 | 12 | ||
> 10 | 5 | 5 | ||
ADC values(×10−3 s/m2) | 817 ± 144 (558–1120) | 1223 ± 473 (460–2230) | 0.002 | |
Septa | 0.121 | |||
Present/Absent | 6/14 | 5/29 | ||
Lymph node | 0.913 | |||
Present/Absent | 0/18 | 0/34 | ||
Pelvic fluid | 0.031 | 8.130 | ||
Physiological/ Pathological | 17/1 | 23/11 | ||
Clinical findings | ||||
Age(years) | 48.2 ± 15.1(24–79) | 54.8 ± 15.0(21–81) | 0.139 | |
Vaginal discharge/bleeding | 1 | 0 | 0.106 | |
Menstruation | ||||
Regular(irregular) | 9(4) | 18(5) | 0.607 | |
Menopause | 9 | 16 | ||
Accompanying lesions | 0.280 | |||
Yes/ No | 7/12 | 9/25 |